BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10023017)

  • 1. Structure and expression of variant BRCA2a lacking the transactivation domain.
    Zou JP; Hirose Y; Siddique H; Rao VN; Reddy ES
    Oncol Rep; 1999; 6(2):437-40. PubMed ID: 10023017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.
    Rajan JV; Marquis ST; Gardner HP; Chodosh LA
    Dev Biol; 1997 Apr; 184(2):385-401. PubMed ID: 9133444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue.
    Bièche I; Lidereau R
    Cancer Res; 1999 Jun; 59(11):2546-50. PubMed ID: 10363970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
    Teng DH; Bogden R; Mitchell J; Baumgard M; Bell R; Berry S; Davis T; Ha PC; Kehrer R; Jammulapati S; Chen Q; Offit K; Skolnick MH; Tavtigian SV; Jhanwar S; Swedlund B; Wong AK; Kamb A
    Nat Genet; 1996 Jun; 13(2):241-4. PubMed ID: 8640236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from BRCA1 and BRCA2.
    Zheng L; Li S; Boyer TG; Lee WH
    Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
    Tavtigian SV; Simard J; Rommens J; Couch F; Shattuck-Eidens D; Neuhausen S; Merajver S; Thorlacius S; Offit K; Stoppa-Lyonnet D; Belanger C; Bell R; Berry S; Bogden R; Chen Q; Davis T; Dumont M; Frye C; Hattier T; Jammulapati S; Janecki T; Jiang P; Kehrer R; Leblanc JF; Mitchell JT; McArthur-Morrison J; Nguyen K; Peng Y; Samson C; Schroeder M; Snyder SC; Steele L; Stringfellow M; Stroup C; Swedlund B; Swense J; Teng D; Thomas A; Tran T; Tranchant M; Weaver-Feldhaus J; Wong AK; Shizuya H; Eyfjord JE; Cannon-Albright L; Tranchant M; Labrie F; Skolnick MH; Weber B; Kamb A; Goldgar DE
    Nat Genet; 1996 Mar; 12(3):333-7. PubMed ID: 8589730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice.
    Blackshear PE; Goldsworthy SM; Foley JF; McAllister KA; Bennett LM; Collins NK; Bunch DO; Brown P; Wiseman RW; Davis BJ
    Oncogene; 1998 Jan; 16(1):61-8. PubMed ID: 9467943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family.
    Nordling M; Karlsson P; Wahlström J; Engwall Y; Wallgren A; Martinsson T
    Cancer Res; 1998 Apr; 58(7):1372-5. PubMed ID: 9537232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
    Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
    Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 and BRCA2 have a limited role in familial prostate cancer.
    Sinclair CS; Berry R; Schaid D; Thibodeau SN; Couch FJ
    Cancer Res; 2000 Mar; 60(5):1371-5. PubMed ID: 10728701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel alternative spliced variant of the transcription factor AP2alpha is expressed in the murine ocular lens.
    Ohtaka-Maruyama C; Hanaoka F; Chepelinsky AB
    Dev Biol; 1998 Oct; 202(1):125-35. PubMed ID: 9758708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
    Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
    Armes JE; Trute L; White D; Southey MC; Hammet F; Tesoriero A; Hutchins AM; Dite GS; McCredie MR; Giles GG; Hopper JL; Venter DJ
    Cancer Res; 1999 Apr; 59(8):2011-7. PubMed ID: 10213514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BRCA2 is a histone acetyltransferase.
    Siddique H; Zou JP; Rao VN; Reddy ES
    Oncogene; 1998 Apr; 16(17):2283-5. PubMed ID: 9619837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of expressed sequences that include a gene for familial breast cancer (BRCA2) and other novel transcripts from a five megabase region on chromosome 13q12.
    Jacob AN; Kandpal G; Kandpal RP
    Oncogene; 1996 Jul; 13(1):213-21. PubMed ID: 8700550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA2 mutations in primary breast and ovarian cancers.
    Lancaster JM; Wooster R; Mangion J; Phelan CM; Cochran C; Gumbs C; Seal S; Barfoot R; Collins N; Bignell G; Patel S; Hamoudi R; Larsson C; Wiseman RW; Berchuck A; Iglehart JD; Marks JR; Ashworth A; Stratton MR; Futreal PA
    Nat Genet; 1996 Jun; 13(2):238-40. PubMed ID: 8640235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.
    Thorlacius S; Olafsdottir G; Tryggvadottir L; Neuhausen S; Jonasson JG; Tavtigian SV; Tulinius H; Ogmundsdottir HM; Eyfjörd JE
    Nat Genet; 1996 May; 13(1):117-9. PubMed ID: 8673089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.